A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
Zhong Xue, Maohua Chen, Mingzuo Wang, Fan Zhang, Zhaoshuo Chen · 2024
Read A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag by Zhong Xue, Maohua Chen, Mingzuo Wang, Fan Zhang, Zhaoshuo Chen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574250.txt.
Description
Zhong Xue and four colleagues present a 2024 safety study mining America's adverse event database for the real-world profile of avatrombopag. The drug raises platelet counts in liver disease and immune thrombocytopenia. Trial data cannot cover rare or late harms, so the team sifted over twelve hundred reports filed between 2018 and 2023 with four statistical signal methods.
Thirty-two event types were tied to the drug. Familiar ones from the label appeared, including clotting, headache, bruising, and bleeding gums, alongside unlisted surprises like flashes of light in vision and ear discomfort. Most events, serious or not, clustered in the first thirty days of treatment. The authors offer the timing and the new signals as practical cautions for prescribers.
Catalog record
| CREATOR | Zhong Xue, Maohua Chen, Mingzuo Wang, Fan Zhang, Zhaoshuo Chen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |